DaVita, Inc. (DVA)
178.69
+2.34
(+1.33%)
USD |
NYSE |
Oct 02, 16:00
178.79
+0.10
(+0.06%)
Pre-Market: 20:00
DaVita Enterprise Value : 24.97B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 24.97B |
| October 01, 2026 | 24.83B |
| September 30, 2026 | 24.75B |
| September 29, 2026 | 24.76B |
| September 28, 2026 | 24.93B |
| September 25, 2026 | 24.96B |
| September 24, 2026 | 24.73B |
| September 23, 2026 | 25.23B |
| September 22, 2026 | 25.27B |
| September 21, 2026 | 25.18B |
| September 18, 2026 | 25.27B |
| September 17, 2026 | 25.23B |
| September 16, 2026 | 25.86B |
| September 15, 2026 | 25.69B |
| September 14, 2026 | 25.59B |
| September 11, 2026 | 25.14B |
| September 10, 2026 | 25.13B |
| September 09, 2026 | 25.22B |
| September 08, 2026 | 25.05B |
| September 04, 2026 | 25.28B |
| September 03, 2026 | 25.14B |
| September 02, 2026 | 25.01B |
| September 01, 2026 | 24.82B |
| August 31, 2026 | 24.81B |
| August 28, 2026 | 25.09B |
| Date | Value |
|---|---|
| August 27, 2026 | 24.98B |
| August 26, 2026 | 25.05B |
| August 25, 2026 | 24.92B |
| August 24, 2026 | 24.84B |
| August 21, 2026 | 24.68B |
| August 20, 2026 | 24.77B |
| August 19, 2026 | 24.89B |
| August 18, 2026 | 24.92B |
| August 17, 2026 | 24.85B |
| August 14, 2026 | 25.05B |
| August 13, 2026 | 25.00B |
| August 12, 2026 | 25.14B |
| August 11, 2026 | 24.95B |
| August 10, 2026 | 25.26B |
| August 07, 2026 | 25.27B |
| August 06, 2026 | 25.09B |
| August 05, 2026 | 25.56B |
| August 04, 2026 | 27.86B |
| August 03, 2026 | 28.20B |
| July 31, 2026 | 28.58B |
| July 30, 2026 | 28.50B |
| July 29, 2026 | 28.63B |
| July 28, 2026 | 28.54B |
| July 27, 2026 | 28.35B |
| July 24, 2026 | 28.30B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 31.81B |
| Labcorp Holdings, Inc. | 31.60B |
| Lifestance Health Group, Inc. | 4.768B |
| Progyny, Inc. | 1.743B |
| Acadia Healthcare Co., Inc. | 5.156B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 343.22M |
| Revenue (Quarterly) | 3.554B |
| Total Expenses (Quarterly) | 3.289B |
| EPS Diluted (Quarterly) | 4.016 |
| Gross Profit Margin (Quarterly) | 27.98% |
| Profit Margin (Quarterly) | 9.66% |
| Earnings Yield | 6.64% |
| Operating Earnings Yield | 16.72% |
| Normalized Earnings Yield | 6.725 |